Literature DB >> 24751385

Survival of motor neuron protein downregulates miR-9 expression in patients with spinal muscular atrophy.

Li-Ting Wang1, Shyh-Shin Chiou2, Yu-Mei Liao2, Yuh-Jyh Jong1, Shih-Hsien Hsu3.   

Abstract

Spinal muscular atrophy (SMA) is a lethal hereditary disease caused by homozygous absence of the survival of the motor neuron (SMN) 1 gene (SMN1), and it is the leading genetic cause of infant mortality. The severity of SMA is directly correlated with SMN protein levels in affected patients; however, the cellular regulatory mechanisms for SMN protein expression are not completely understood. In this study, we investigated the regulatory effects between SMN expression and miR-9a, a downstream noncoding small RNA. Using an inducible SMN short hairpin RNA interference (shRNAi) system in NSC 34 and human skin fibroblast cells, cellular miR-9 levels and SMN protein repression were time-dependently upregulated. Conversely, cellular miR-9 levels decreased when HeLa cells were transfected with SMN protein fused with green fluorescent protein. In SMA-like mice spinal cords and human primary skin fibroblasts isolated from patients with different degrees of SMA, human SMN exhibited a disease severity-dependent decrease, whereas cellular miR-9 levels increased. These results clearly suggested that cellular SMN proteins regulated miR-9 expression and that miR-9 expression was related to SMA severity. Thus, miR-9 may be a marker for SMA prognosis.
Copyright © 2014. Published by Elsevier B.V.

Entities:  

Keywords:  Spinal muscular atrophy; Survival of motor neuron; miR-9

Mesh:

Substances:

Year:  2014        PMID: 24751385     DOI: 10.1016/j.kjms.2013.12.007

Source DB:  PubMed          Journal:  Kaohsiung J Med Sci        ISSN: 1607-551X            Impact factor:   2.744


  10 in total

1.  miR-206 Reduces the Severity of Motor Neuron Degeneration in the Facial Nuclei of the Brainstem in a Mouse Model of SMA.

Authors:  Valeria Valsecchi; Serenella Anzilotti; Angelo Serani; Giusy Laudati; Paola Brancaccio; Natascia Guida; Ornella Cuomo; Giuseppe Pignataro; Lucio Annunziato
Journal:  Mol Ther       Date:  2020-01-15       Impact factor: 11.454

Review 2.  Diverse role of survival motor neuron protein.

Authors:  Ravindra N Singh; Matthew D Howell; Eric W Ottesen; Natalia N Singh
Journal:  Biochim Biophys Acta Gene Regul Mech       Date:  2017-01-15       Impact factor: 4.490

3.  AAV9-mediated delivery of miR-23a reduces disease severity in Smn2B/-SMA model mice.

Authors:  Kevin A Kaifer; Eric Villalón; Benjamin S O'Brien; Samantha L Sison; Caley E Smith; Madeline E Simon; Jose Marquez; Siri O'Day; Abigail E Hopkins; Rachel Neff; Hansjörg Rindt; Allison D Ebert; Christian L Lorson
Journal:  Hum Mol Genet       Date:  2019-10-01       Impact factor: 6.150

Review 4.  RNA in spinal muscular atrophy: therapeutic implications of targeting.

Authors:  Ravindra N Singh; Joonbae Seo; Natalia N Singh
Journal:  Expert Opin Ther Targets       Date:  2020-06-25       Impact factor: 6.902

Review 5.  Neuromuscular Junctions as Key Contributors and Therapeutic Targets in Spinal Muscular Atrophy.

Authors:  Marina Boido; Alessandro Vercelli
Journal:  Front Neuroanat       Date:  2016-02-03       Impact factor: 3.856

Review 6.  miRNA in spinal muscular atrophy pathogenesis and therapy.

Authors:  Francesca Magri; Fiammetta Vanoli; Stefania Corti
Journal:  J Cell Mol Med       Date:  2017-11-21       Impact factor: 5.310

7.  Decreased microRNA levels lead to deleterious increases in neuronal M2 muscarinic receptors in Spinal Muscular Atrophy models.

Authors:  Patrick J O'Hern; Inês do Carmo G Gonçalves; Johanna Brecht; Eduardo Javier López Soto; Jonah Simon; Natalie Chapkis; Diane Lipscombe; Min Jeong Kye; Anne C Hart
Journal:  Elife       Date:  2017-05-02       Impact factor: 8.140

Review 8.  MotomiRs: miRNAs in Motor Neuron Function and Disease.

Authors:  Zachary C E Hawley; Danae Campos-Melo; Cristian A Droppelmann; Michael J Strong
Journal:  Front Mol Neurosci       Date:  2017-05-04       Impact factor: 5.639

Review 9.  Circulating microRNAs as potential biomarkers and therapeutic targets in spinal muscular atrophy.

Authors:  Tai-Heng Chen
Journal:  Ther Adv Neurol Disord       Date:  2020-12-25       Impact factor: 6.570

10.  Altered Levels of MicroRNA-9, -206, and -132 in Spinal Muscular Atrophy and Their Response to Antisense Oligonucleotide Therapy.

Authors:  Francesco Catapano; Irina Zaharieva; Mariacristina Scoto; Elena Marrosu; Jennifer Morgan; Francesco Muntoni; Haiyan Zhou
Journal:  Mol Ther Nucleic Acids       Date:  2016-07-05       Impact factor: 10.183

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.